Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
On Leave from a Bachelor of Science
(2009 - 2011)
(2007 - 2009)
2024
2024
2023
2023
2011
2011
The Longevity Fund is a specialty life science venture capital firm focused on pharmaceutical companies developing therapies for aging-associated pathology. Our team identifies pioneering science that holds the promise of addressing late-onset medical conditions and works with scientists and entrepreneurs to advance enterprises that can translate research into effective preclinical drug development programs. We welcome proposals from companies and laboratories with translational research in this area.
2015 - 2016
2015 - 2016
Alexo Therapeutics was formed in 2015 as an independent, private biotech company, located in South San Francisco. We are developing new protein-based therapeutics to treat cancer.
2011 - 2013
2011 - 2013
Peter Thiel, PayPal founder and original Facebook investor, grants 24 young entrepreneurs $100,000 to move to Silicon Valley and pursue 'game-changing' entrepreneurial ventures.
2011 - 2011
2011 - 2011
Screened using biochemical and cell-based assays to identify a promising therapeutic target for a lung cancer subtype with no effective targeted therapy. Co-first authorship publication in Clinical Cancer Research from 3 months of intense research. Presented results at a poster session and department-wide meeting.
2010 - 2011
2010 - 2011
Studying development and morphogenesis, mimicking nature with pattern-forming genetic circuits. Helping to develop novel DNA construction techniques, independently designing and assemblng complex genetic constructs to assay pattern formation via programmed cell-cell adhesion.
2010 - 2010
2010 - 2010
Collaborated in a team to build a set of cell lines to act as a 'cellular touchpad'. Engineered cells to respond to pressure, synthesized a genetic switch circuit, and artificially modulated bone differentiation. Planned complete experimental outline, from DNA sequence design, to bacterial plasmid construction, to implementation in mammalian tissue culture. Organized a poster and helped create a public website to explain the project. Presented results at a three-day synthetic biology conference.
2009 - 2010
2009 - 2010
Investigated the therapeutic potential of SIRT1 in mammalian aging and osteoporosis. Preformed biochemical assays to investigate protein function. Worked with mutant mouse lines to establish osteoporotic assays. Independently conducted experiments while organizing sample delivery to collaborators in Edinburgh.
2006 - 2009
2006 - 2009
Worked full-time for 3 years in a C. elegans biology lab, exploring the effects of genetic and environmental signals on the aging process. Identified two candidate age-modulating proteins in the somatic gonad pathway. Presented results at biannual group meetings. Prepared a short manuscript to explain the project to a public audience.